Lymphoma News and Research

RSS
Lymphoma is cancer that begins in cells of the immune system. There are two basic categories of lymphomas. One kind is Hodgkin lymphoma, which is marked by the presence of a type of cell called the Reed-Sternberg cell. The other category is non-Hodgkin lymphomas, which includes a large, diverse group of cancers of immune system cells. Non-Hodgkin lymphomas can be further divided into cancers that have an indolent (slow-growing) course and those that have an aggressive (fast-growing) course. These subtypes behave and respond to treatment differently. Both Hodgkin and non-Hodgkin lymphomas can occur in children and adults, and prognosis and treatment depend on the stage and the type of cancer.
FDA approves expanded use of Zykadia for first-line treatment of ALK-positive metastatic NSCLC

FDA approves expanded use of Zykadia for first-line treatment of ALK-positive metastatic NSCLC

FDA grants accelerated approval to cancer treatment based on common biomarker

FDA grants accelerated approval to cancer treatment based on common biomarker

Study shows how different genetic mutations cause acute myeloid leukemia

Study shows how different genetic mutations cause acute myeloid leukemia

Cancer drug may help treat food allergies

Cancer drug may help treat food allergies

New findings shed light on factors that impact hospice referrals for patients with blood cancers

New findings shed light on factors that impact hospice referrals for patients with blood cancers

Cedars-Sinai researchers analyze social media posts to find medication concerns of IBD patients

Cedars-Sinai researchers analyze social media posts to find medication concerns of IBD patients

Researchers explore new treatment combination for pediatric patients with Hodgkin lymphoma

Researchers explore new treatment combination for pediatric patients with Hodgkin lymphoma

Study finds no clear benefit of stem-cell transplant for double-hit lymphoma patients in remission

Study finds no clear benefit of stem-cell transplant for double-hit lymphoma patients in remission

Scientists discover free C3d protein that mitigates tumor-induced immunosuppression

Scientists discover free C3d protein that mitigates tumor-induced immunosuppression

AbbVie introduces new mindfulness podcast audio recordings for blood cancer patients

AbbVie introduces new mindfulness podcast audio recordings for blood cancer patients

UT Health scientists discover epigenetic changes that contribute to AML

UT Health scientists discover epigenetic changes that contribute to AML

Studies pave way for genome-targeted treatments in pancreatic cancer

Studies pave way for genome-targeted treatments in pancreatic cancer

WHO to launch pilot project for prequalifying biosimilar cancer medicines

WHO to launch pilot project for prequalifying biosimilar cancer medicines

Study finds more severe coronary artery disease in Hodgkin lymphoma survivors after chest irradiation

Study finds more severe coronary artery disease in Hodgkin lymphoma survivors after chest irradiation

Researchers show how Epstein-Barr virus manages to persist inside immune system's B cells

Researchers show how Epstein-Barr virus manages to persist inside immune system's B cells

Study suggests how existing and emerging immunotherapy treatments could be successful for sarcomas

Study suggests how existing and emerging immunotherapy treatments could be successful for sarcomas

Formaldehyde exposure not linked to leukemia, research shows

Formaldehyde exposure not linked to leukemia, research shows

TACC's supercomputers assist in discovery of new, better chemotherapy drugs

TACC's supercomputers assist in discovery of new, better chemotherapy drugs

Takeda announces accelerated approval from FDA for new lung cancer treatment

Takeda announces accelerated approval from FDA for new lung cancer treatment

Scientists announce ‘outstanding’ results of new blood cancer study

Scientists announce ‘outstanding’ results of new blood cancer study